{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T17:47:50Z","timestamp":1763142470231,"version":"3.44.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,5]]},"DOI":"10.7759\/cureus.91687","type":"journal-article","created":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T00:14:52Z","timestamp":1757117692000},"source":"Crossref","is-referenced-by-count":2,"title":["A Case of Drug-Induced Immune Thrombocytopenia Caused by Haloperidol"],"prefix":"10.7759","author":[{"given":"Yoshihiko","family":"Kanno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinao","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuya","family":"Takita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200427150-00007","article-title":"Drug-induced immune thrombocytopenia","volume":"27","author":"van den Bemt PM","year":"2004","unstructured":"van den Bemt PM, Meyboom RH, Egberts AC. Drug-induced immune thrombocytopenia. Drug Saf. 2004, 27:1243-52. 10.2165\/00002018-200427150-00007","journal-title":"Drug Saf"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-190945","article-title":"Comparative analysis of hospital outcomes for thrombotic thrombocytopenic purpura between 2018 and 20120: a national inpatient sample database study","volume":"142","author":"Neupane N","year":"2023","unstructured":"Neupane N, Srivastava A, Agrawal S, Mahmoud A, Saeed H, Kouides PA. Comparative analysis of hospital outcomes for thrombotic thrombocytopenic purpura between 2018 and 20120: a national inpatient sample database study. Blood. 2023, 142:5543. 10.1182\/blood-2023-190945","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.33590\/emjallergyimmunol\/10306610","article-title":"Drug-induced thrombocytopenic purpura: a systematic review and meta-analysis of case reports","volume":"8","author":"Bhardwaj A","year":"2023","unstructured":"Bhardwaj A, Gupta R. Drug-induced thrombocytopenic purpura: a systematic review and meta-analysis of case reports. EMJ Allergy Immunol. 2023, 8:70-9. 10.33590\/emjallergyimmunol\/10306610","journal-title":"EMJ Allergy Immunol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.21307\/immunohematology-2019-099","article-title":"Drug-induced immune thrombocytopenia: incidence, clinical features, laboratory testing, and pathogenic mechanisms","volume":"30","author":"Curtis BR","year":"2014","unstructured":"Curtis BR. Drug-induced immune thrombocytopenia: incidence, clinical features, laboratory testing, and pathogenic mechanisms. Immunohematology. 2014, 30:55-65. 10.21307\/immunohematology-2019-099","journal-title":"Immunohematology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-016-0469-y","article-title":"Vancomycin-induced thrombocytopenia: a narrative review","volume":"40","author":"Mohammadi M","year":"2017","unstructured":"Mohammadi M, Jahangard-Rafsanjani Z, Sarayani A, Hadjibabaei M, Taghizadeh-Ghehi M. Vancomycin-induced thrombocytopenia: a narrative review. Drug Saf. 2017, 40:49-59. 10.1007\/s40264-016-0469-y","journal-title":"Drug Saf"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-129-11_part_1-199812010-00009","article-title":"Drug-induced thrombocytopenia: a systematic review of published case reports","volume":"129","author":"George JN","year":"1998","unstructured":"George JN, Raskob GE, Shah SR, Rizvi MA, Hamilton SA, Osborne S, Vondracek T. Drug-induced thrombocytopenia: a systematic review of published case reports. Ann Intern Med. 1998, 129:886-90. 10.7326\/0003-4819-129-11_part_1-199812010-00009","journal-title":"Ann Intern Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12052","article-title":"A systematic evaluation of laboratory testing for drug-induced immune thrombocytopenia","volume":"11","author":"Arnold DM","year":"2013","unstructured":"Arnold DM, Kukaswadia S, Nazi I, et al.. A systematic evaluation of laboratory testing for drug-induced immune thrombocytopenia. J Thromb Haemost. 2013, 11:169-76. 10.1111\/jth.12052","journal-title":"J Thromb Haemost"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/070674378703200213","article-title":"Thrombocytopenia associated with chlorpromazine, haloperidol and thiothixene: a case report","volume":"32","author":"Balon R","year":"1987","unstructured":"Balon R, Berchou R, Zethelius M. Thrombocytopenia associated with chlorpromazine, haloperidol and thiothixene: a case report. Can J Psychiatry. 1987, 32:149-50. 10.1177\/070674378703200213","journal-title":"Can J Psychiatry"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-020-01649-2","article-title":"An unwanted reaction by the use of haloperidol in hyperkinetic delirium","volume":"33","author":"Remelli F","year":"2021","unstructured":"Remelli F, Bugada M, Matteucci G, Brunori M, Gianotti G, Zurlo A, Volpato S. An unwanted reaction by the use of haloperidol in hyperkinetic delirium. Aging Clin Exp Res. 2021, 33:1409-11. 10.1007\/s40520-020-01649-2","journal-title":"Aging Clin Exp Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijnurstu.2024.104959","article-title":"Global incidence and prevalence of delirium and its risk factors in medically hospitalized older patients: a systematic review and meta-analysis","volume":"162","author":"Wu CR","year":"2025","unstructured":"Wu CR, Chang KM, Tranyor V, Chiu HY. Global incidence and prevalence of delirium and its risk factors in medically hospitalized older patients: a systematic review and meta-analysis. Int J Nurs Stud. 2025, 162:104959. 10.1016\/j.ijnurstu.2024.104959","journal-title":"Int J Nurs Stud"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12123897","article-title":"Delirium in medically hospitalized patients: prevalence, recognition and risk factors: a prospective cohort study","volume":"12","author":"Al Farsi RS","year":"2023","unstructured":"Al Farsi RS, Al Alawi AM, Al Huraizi AR, Al-Saadi T, Al-Hamadani N, Al Zeedy K, Al-Maqbali JS. Delirium in medically hospitalized patients: prevalence, recognition and risk factors: a prospective cohort study. J Clin Med. 2023, 12:10.3390\/jcm12123897","journal-title":"J Clin Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.24983\/scitemed.cmt.2018.00085","article-title":"Epidemiology, mechanisms, diagnosis, and treatment of delirium: a narrative review","volume":"1","author":"Ospina JP","year":"2018","unstructured":"Ospina JP, King IV F, Madva E, Celano CM. Epidemiology, mechanisms, diagnosis, and treatment of delirium: a narrative review. Clin Med Ther. 2018, 1:3. 10.24983\/scitemed.cmt.2018.00085","journal-title":"Clin Med Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-07-2175","article-title":"Drug-induced thrombocytopenia: localization of the binding site of GPIX-specific quinine-dependent antibodies","volume":"102","author":"Asvadi P","year":"2003","unstructured":"Asvadi P, Ahmadi Z, Chong BH. Drug-induced thrombocytopenia: localization of the binding site of GPIX-specific quinine-dependent antibodies. Blood. 2003, 102:1670-7. 10.1182\/blood-2002-07-2175","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v77.12.2668.bloodjournal77122668","article-title":"Characteristics of quinine- and quinidine-induced antibodies specific for platelet glycoproteins IIb and IIIa","volume":"77","author":"Visentin GP","year":"1991","unstructured":"Visentin GP, Newman PJ, Aster RH. Characteristics of quinine- and quinidine-induced antibodies specific for platelet glycoproteins IIb and IIIa. Blood. 1991, 77:2668-76. 10.1182\/blood.v77.12.2668.bloodjournal77122668","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/trf.12138","article-title":"Prolonged ceftriaxone-induced immune thrombocytopenia due to impaired drug clearance: a case report","volume":"53","author":"Jacquot C","year":"2013","unstructured":"Jacquot C, Moayeri M, Kim B, Shugarts S, Lynch KL, Leavitt AD. Prolonged ceftriaxone-induced immune thrombocytopenia due to impaired drug clearance: a case report. Transfusion. 2013, 53:2715-21. 10.1111\/trf.12138","journal-title":"Transfusion"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198406000-00003","article-title":"Neuroleptic drug-induced changes in platelet levels","volume":"4","author":"Holt RJ","year":"1984","unstructured":"Holt RJ. Neuroleptic drug-induced changes in platelet levels. J Clin Psychopharmacol. 1984, 4:130-2. 10.1097\/00004714-198406000-00003","journal-title":"J Clin Psychopharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/411415-a-case-of-drug-induced-immune-thrombocytopenia-caused-by-haloperidol","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T00:14:53Z","timestamp":1757117693000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/411415-a-case-of-drug-induced-immune-thrombocytopenia-caused-by-haloperidol"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,5]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.91687","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,5]]}}}